These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 314664)
1. [The prognostic value of immunologic markers in juvenile acute lymphatic leukemias and non-Hodgkin lymphomas]. Plüss HJ; Joller PW; Hitzig WH; Jakob M Schweiz Med Wochenschr; 1979 Sep; 109(37):1379-82. PubMed ID: 314664 [TBL] [Abstract][Full Text] [Related]
2. Lack of influence of T-cell marker and importance of mediastinal mass on the prognosis of acute lymphocytic leukemias of childhood. Hann HW; Lustbader ED; Evans AE; Toledano SR; Lillie PD; Jasko LB J Natl Cancer Inst; 1981 Feb; 66(2):285-90. PubMed ID: 6969813 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic value of T-cell markers in juvenile acute lymphatic leukemia]. Plüss HJ; Joller PW; Hitzig WH Schweiz Med Wochenschr; 1981 Oct; 111(41):1527-9. PubMed ID: 6975993 [TBL] [Abstract][Full Text] [Related]
4. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
5. Results of multiparameter studies of T-cell lymphoid neoplasms. Collins RD; Waldron JA; Glick AD Am J Clin Pathol; 1979 Oct; 72(4 Suppl):699-707. PubMed ID: 386780 [TBL] [Abstract][Full Text] [Related]
6. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing. Deegan MJ Arch Pathol Lab Med; 1989 Jun; 113(6):606-18. PubMed ID: 2658905 [TBL] [Abstract][Full Text] [Related]
7. [Treatment of primary mediastinal large B-cell lymphomas]. Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753 [TBL] [Abstract][Full Text] [Related]
8. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047 [TBL] [Abstract][Full Text] [Related]
9. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
10. [Progress in the treatment of non-Hodgkin's lymphoma (NHL) in children. The report of Polish Pediatric Leukaemia/lymphoma Study Group (PPLLSG)]. Wróbel G; Kazanowska B; Chybicka A; Jeleń M; Małdyk J; Sowińska E; Balcerska A; Balwierz W; Bubała H; Kołakowska-Mrozowska B; Kołtan A; Korzon M; Kowalczyk J; Krawczuk-Rybak M; Maciejka-Kapuścińska L; Matysiak M; Płoszyńska A; Popadiuk S; Solarz E; Sońta-Jakimczyk D; Sopyło B; Stańczak E; Stefaniak J; Stefańska K; Wachowiak J; Wieczorek M; Wysocki M Przegl Lek; 2004; 61 Suppl 2():45-8. PubMed ID: 15686045 [TBL] [Abstract][Full Text] [Related]
11. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma]. Kamieńska E Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116 [TBL] [Abstract][Full Text] [Related]
13. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas]. Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549 [TBL] [Abstract][Full Text] [Related]
14. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000. Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H; Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465 [TBL] [Abstract][Full Text] [Related]
15. Outcome and prognostic factors in ocular adnexal lymphoma. Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428 [TBL] [Abstract][Full Text] [Related]
17. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms]. Huber H; Gattringer C; Thaler J; Peschel C Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283 [TBL] [Abstract][Full Text] [Related]
18. Immunologically defined subclasses of acute lymphoblastic leukaemia in children: their relationship to presentation features and prognosis. Greaves MF; Janossy G; Peto J; Kay H Br J Haematol; 1981 Jun; 48(2):179-97. PubMed ID: 7016165 [TBL] [Abstract][Full Text] [Related]
19. Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma. Lee SM; Ryder WD; Clemons MJ; Morgenstern GR; Chang J; Scarffe JH; Radford JA Bone Marrow Transplant; 1999 Aug; 24(3):271-7. PubMed ID: 10455365 [TBL] [Abstract][Full Text] [Related]
20. Leukemias and lymphomas of thymic differentiation. Borowitz MJ; Falletta JM Clin Lab Med; 1988 Mar; 8(1):119-34. PubMed ID: 2896085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]